However, when we analyzed the HIPK2 mRNA expression in our pancreatic cancer samples [41] (i.e., 26 out of 44 samples in which tumor mRNA was available) we did not find a consistent matching between the mRNA levels and the protein positivity by IHC (data not shown). This evidence concerns the gene HIPK2 and familial pancreatic carcinoma.